BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35410048)

  • 21. The Xpert® MTB/RIF assay in routine diagnosis of pulmonary tuberculosis: A multicentre study in Lithuania.
    Pimkina E; Zablockis R; Nikolayevskyy V; Danila E; Davidaviciene E
    Respir Med; 2015 Nov; 109(11):1484-9. PubMed ID: 26403251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Active case finding of rifampicin sensitive and resistant TB among household contacts of drug resistant TB patients in Andhra Pradesh and Telangana states of India - A systematic screening intervention.
    Chatla C; Jaju J; Achanta S; Samyuktha R; Chakramahanti S; Purad C; Chepuri R; Nair SA; Parmar M
    Indian J Tuberc; 2018 Jul; 65(3):218-224. PubMed ID: 29933863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study.
    Boehme CC; Nicol MP; Nabeta P; Michael JS; Gotuzzo E; Tahirli R; Gler MT; Blakemore R; Worodria W; Gray C; Huang L; Caceres T; Mehdiyev R; Raymond L; Whitelaw A; Sagadevan K; Alexander H; Albert H; Cobelens F; Cox H; Alland D; Perkins MD
    Lancet; 2011 Apr; 377(9776):1495-505. PubMed ID: 21507477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multidrug Resistant Mycobacterium tuberculosis Among Military and Civilian Personnel seen at a Tertiary Military Hospital, Manila, Philippines (2015-2018).
    Velasco JM; Gaurano N; Valderama MT; Nogrado K; Diones PC; Lopez MN; Liao C; Chua D; Develos M; Fernandez S; Macareo L; Swierczewski B
    Mil Med; 2020 Aug; 185(7-8):e1106-e1111. PubMed ID: 31915831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of the diagnostic performance of Xpert MTB/RIF test for the detection of Mycobacterium tuberculosis and rifampin resistance in clinical samples].
    Gürsoy NC; Yakupoğulları Y; Tekerekoğlu MS; Otlu B
    Mikrobiyol Bul; 2016 Apr; 50(2):196-204. PubMed ID: 27175492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Case report of a false positive result of the Xpert
    Claessens J; Mathys V; Derdelinckx I; Saegeman V
    Acta Clin Belg; 2017 Jun; 72(3):195-197. PubMed ID: 26400761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Xpert MTB/RIF for TB diagnosis in a primary care clinic with high TB and HIV prevalence in South Africa: a pragmatic randomised trial.
    Cox HS; Mbhele S; Mohess N; Whitelaw A; Muller O; Zemanay W; Little F; Azevedo V; Simpson J; Boehme CC; Nicol MP
    PLoS Med; 2014 Nov; 11(11):e1001760. PubMed ID: 25423041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accuracy of the InnowaveDX MTB/RIF test for detection of
    Deng Y; Ma Z; Su B; Bai G; Pan J; Wang Q; Cai L; Song Y; Shang Y; Ma P; Li J; Zhou Q; Mulati G; Fan D; Li S; Tan Y; Pang Y
    Emerg Microbes Infect; 2023 Dec; 12(1):2151382. PubMed ID: 36416478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing the utility of the Xpert Mycobacterium tuberculosis/rifampin assay for analysis of bronchoalveolar lavage fluid in patients with suspected pulmonary tuberculosis.
    Bai W; Liu L; Wu L; Chen S; Wu S; Wang Z; Xu K; Chi Q; Pan Y; Xu X
    J Clin Lab Anal; 2022 Jan; 36(1):e24154. PubMed ID: 34850984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Xpert MTB/RIF in the Diagnosis of Childhood Tuberculosis in Rural Ethiopia.
    Pérez-Butragueño M; Ramos-Rincón JM; Tesfamariam A; Comeche B; Mohammed N; Tiziano G; Endirays J; Biru D; Elala T; Edri A; Prieto L; Górgolas M
    J Trop Pediatr; 2022 Jun; 68(4):. PubMed ID: 35848941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Xpert
    Zawedde-Muyanja S; Manabe YC; Sewankambo NK; Nakiyingi L; Nakanjako D
    Int J Tuberc Lung Dis; 2018 Dec; 22(12):1475-1480. PubMed ID: 30606320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance of the G4 Xpert
    Dharan NJ; Blakemore R; Sloutsky A; Kaur D; Alexander RC; Ghajar M; Musser KA; Escuyer VE; Rowlinson MC; Crowe S; Laniado-Laborin R; Valli E; Nabeta P; Johnson P; Alland D
    BMC Infect Dis; 2016 Dec; 16(1):764. PubMed ID: 27993132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of Introducing Xpert MTB/RIF on Diagnosis and Treatment of Drug-Resistant Tuberculosis Patients in Indonesia: A Pre-Post Intervention Study.
    van Kampen SC; Susanto NH; Simon S; Astiti SD; Chandra R; Burhan E; Farid MN; Chittenden K; Mustikawati DE; Alisjahbana B
    PLoS One; 2015; 10(6):e0123536. PubMed ID: 26075722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children.
    Kay AW; González Fernández L; Takwoingi Y; Eisenhut M; Detjen AK; Steingart KR; Mandalakas AM
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013359. PubMed ID: 32853411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of tests done, and tuberculosis cases detected by Xpert® MTB/RIF and Xpert® MTB/RIF-Ultra in Uganda.
    Kakinda M; Tugumisirize D; Nyombi A; Mugisha M; Turyahabwe S; Walusimbi S; Matovu JKB
    PLoS One; 2022; 17(10):e0275960. PubMed ID: 36215286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis of tuberculosis among COVID-19 suspected cases in Ghana.
    Afum T; Asare P; Asante-Poku A; Darko-Otchere I; Morgan PA; Bedeley E; Asandem DA; Musah AB; Siam IM; Tetteh P; Adusi-Poku Y; Frimpong-Manso R; Bonney JHK; Ampofo W; Yeboah-Manu D
    PLoS One; 2021; 16(12):e0261849. PubMed ID: 34962960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low prevalence of MDR-TB in Lao PDR: results from the first national anti-tuberculosis drug resistance survey.
    Iem V; Dean A; Zignol M; Vongvichit P; Inthavong D; Siphanthong S; Sorsavanh T; Kim SJ; Shin S; Sébert J; Chittamany P
    Trop Med Int Health; 2019 Apr; 24(4):421-431. PubMed ID: 30663180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chest X-ray interpretation does not complement Xpert MTB/RIF in diagnosis of smear-negative pulmonary tuberculosis among TB-HIV co-infected adults in a resource-limited setting.
    Nakiyingi L; Bwanika JM; Ssengooba W; Mubiru F; Nakanjako D; Joloba ML; Mayanja-Kizza H; Manabe YC
    BMC Infect Dis; 2021 Jan; 21(1):63. PubMed ID: 33435896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Xpert MTB/RIF and decentralized care on linkage to care and drug-resistant tuberculosis treatment outcomes in Johannesburg, South Africa.
    Evans D; Sineke T; Schnippel K; Berhanu R; Govathson C; Black A; Long L; Rosen S
    BMC Health Serv Res; 2018 Dec; 18(1):973. PubMed ID: 30558670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accuracy of Xpert MTB/RIF Ultra for the Diagnosis of Pleural TB in a Multicenter Cohort Study.
    Wang G; Wang S; Yang X; Sun Q; Jiang G; Huang M; Huo F; Ma Y; Chen X; Huang H
    Chest; 2020 Feb; 157(2):268-275. PubMed ID: 31437432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.